Search Results - "Mathieu, M C"

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.

Authors: Dieci, M. V. Mathieu, M. C. Guarneri, V. et al.

Source: Annals of Oncology. Aug2015, Vol. 26 Issue 8, p1698-1704. 7p.

Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.

Authors: Mathieu, M. C. Mazouni, C. Kesty, N. C. et al.

Source: Annals of Oncology. Aug2012, Vol. 23 Issue 8, p2046-2052. 7p. 3 Charts, 2 Graphs.

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile

Authors: Mathieu, M.-C. Rouzier, R. Llombart-Cussac, A. et al.

Source: European Journal of Cancer. Feb2004, Vol. 40 Issue 3, p342. 10p.

Pathologie des cancers du sein: progrès et perspectives.

Authors: Mathieu, M. -C.¹ mathieu@igr.fr

Source: Oncologie (Tech Science Press). mar/avril2006, Vol. 8 Issue 3, p269-270. 2p.

Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial.

Authors: Mathieu, M. C. Goubar, A. Sigal, B. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p877-878. 2p.

p53 protein overexpression and chemosensitivity in breast cancer. Institut Gustave-Roussy Breast Cancer Group.

Authors: Mathieu, M C Koscielny, S Le Bihan, M L et al.

Source: Lancet. 5/6/1995, Vol. 345 Issue 8958, p1182-1182. 1p.

Diagnostic de l’amplification du gène HER2 dans les cancers du sein: Le point de vue génétique

Alternate Title: Diagnosis of HER2 gene amplification in breast carcinoma

Authors: Couturier, J. Vincent-Salomon, A. Mathieu, M.-C. et al.

Source: Pathologie Biologie. Sep2008, Vol. 56 Issue 6, p375-379. 5p.

Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature.

Authors: Cyrta, J. Andreiuolo, F. Azoulay, S. et al.

Source: Cytopathology. Dec2013, Vol. 24 Issue 6, p377-384. 8p.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.

Authors: Bertucci, F. Orsetti, B. Nègre, V. et al.

Source: Oncogene. 9/11/2008, Vol. 27 Issue 40, p5359-5372. 14p. 1 Diagram, 5 Charts, 4 Graphs.

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients.

Authors: Ady, N. Morat, L. Fizazi, K. et al.

Source: British Journal of Cancer. 1/26/2004, Vol. 90 Issue 2, p443-448. 6p.

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer.

Authors: Arnould, L Denoux, Y MacGrogan, G et al.

Source: British Journal of Cancer. 5/19/2003, Vol. 88 Issue 10, p1587-1591. 5p.

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study.

Authors: Vincent-Salomon, A MacGrogan, G Couturier, J et al.

Source: Histopathology. Apr2003, Vol. 42 Issue 4, p337-347. 11p.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers.

Authors: Ahomadegbe, J C Tourpin, S Kaghad, M et al.

Source: Oncogene. 11/9/2000, Vol. 19 Issue 47, p5413. 6p. 3 Black and White Photographs, 5 Charts, 1 Graph.

Tubular adenoma of the breast with associated mucinous features: a cytological diagnostic trap.

Authors: Calderaro, J. Bayou, E. H. Castaigne, D. et al.

Source: Cytopathology. Jun2010, Vol. 21 Issue 3, p191-193. 3p.

FNAC of a breast lesion after treatment for carcinoma.

Authors: Mansuet-Lupo, A. Laurent, I. Bayou, E. H. et al.

Source: Cytopathology. Oct2008, Vol. 19 Issue 5, p323-325. 3p. 4 Color Photographs, 1 Black and White Photograph.

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study.

Authors: Dieci, M. V. Criscitiello, C. Goubar, A. et al.

Source: Annals of Oncology. Mar2014, Vol. 25 Issue 3, p611-618. 8p.

Étude pilote française de phase II d’irradiation partielle accélérée du sein conformationnelle tridimensionnelle bi-fractionnée hebdomadaire de 40Gy

Alternate Title: Accelerated partial breast irradiation: Bifractionated 40Gy in one week. A French pilot phase II study

Authors: Bourgier, C. Pichenot, C. Verstraet, R. et al.

Source: Cancer Radiothérapie. Dec2010, Vol. 14 Issue 8, p718-726. 9p.

Specimen radiography as predictor of resection margin status in non-palpable breast lesions

Authors: Mazouni, C. Rouzier, R. Balleyguier, C. et al.

Source: Clinical Radiology. Sep2006, Vol. 61 Issue 9, p789-796. 8p.

Retained surgical sponge or gossypiboma of the breast.

Authors: El Khoury, M Mignon, F Tardivon, A et al.

Source: European Journal of Radiology. Apr2002, Vol. 42 Issue 1, p58-61. 4p.

KIT expression in postradiation sarcoma.

Authors: Andreiuolo, F. Calderaro, J. Loriot, Y. et al.

Source: Cytopathology. Aug2010, Vol. 21 Issue 4, p279-280. 2p.